spec sheet7 rows
N-Methyl-Cypenamine is the N-methyl analog of cypenamine (2-phenylcyclopentylamine), a catecholaminergic CNS stimulant research chemical. Like its parent it is presumed to act as a norepinephrine-dopamine releaser and reuptake inhibitor, giving energy and mild mood elevation. It is obscure, gray-market, and lightly studied in humans.
- Alertness and energy
- Motivation
- Mild mood lift
- Cardiovascular strain
- Insomnia
- Anxiety
- Appetite loss
Mechanism
By analogy to cypenamine, it is presumed to raise and through a mix of monoamine release and reuptake inhibition at their transporters, producing arousal and motivation. The rigid cyclopentane-phenyl skeleton is shared with tranylcypromine, but the compound is regarded as a catecholaminergic stimulant rather than a monoamine oxidase inhibitor. The methyl substitution likely modulates potency and duration, though this has not been directly measured.
receptor fingerprint
transporterPresumed release and reuptake inhibition
Presumed release and reuptake inhibition
Safetyrisks and cautions, not medical advice
Treat it as a typical catecholaminergic stimulant: cardiovascular load, insomnia, appetite suppression, anxiety, and redose potential, all with sparse human data. Its structural kinship to the MAOI tranylcypromine means interactions with serotonergic agents and other stimulants should be considered unpredictable and avoided. Do not combine with MAOIs. Not medical advice.
Subjective profileweighing the evidence above
No reason to take it. There is no published work on this compound at all, so everything about it is inferred from a parent that is itself barely studied, and what you get is an ordinary stimulant profile with unknown margins and an unpredictable relationship to serotonergic drugs. Better-characterized stimulants exist for a fraction of the uncertainty.
Resources
This entry is here for reference.
Reviews
My notesprivate to this device
FAQ
How does it compare to N-ethyl-cypenamine?
Both are N-alkyl cypenamine analogs presumed to share its releaser/reuptake-inhibitor action; potency and duration differences are not documented.
Is it a well-studied drug?
No. It is an obscure research chemical with minimal published human data.
Is it safe with antidepressants?
No, treat combinations with serotonergic drugs or MAOIs as dangerous. Not medical advice.
Adverse effects
- Cardiovascular strain
- Insomnia
- Anxiety
- Appetite loss